- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 15, 2026 | 31.18M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 29.36M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 1.86M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$3.62M |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | −$1.26M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $1.91M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $3.06M |
| Cash And Equivalents restated | Q1 2026 · Mar 31, 2025 | $1.36M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $50.9M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $53.61M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $19.2M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $16.33M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $19.35M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $16.61M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $20.38M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $19.38M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $70.26M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $70.22M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.18 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$6.14 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.18 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$6.14 |
| Net Income | Q1 2026 · Mar 31, 2026 | −$5.28M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$6.82M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$5.17M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$4.76M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $50K |